Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000330954 | SCV000414820 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000360527 | SCV000483843 | likely benign | Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000402096 | SCV000483844 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000303068 | SCV000483845 | likely benign | Dilated Cardiomyopathy, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000355563 | SCV000483846 | likely benign | Familial restrictive cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000330954 | SCV001004447 | benign | Primary ciliary dyskinesia | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003418040 | SCV004145521 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | DNAAF3: BP4, BP7 |
Prevention |
RCV003950131 | SCV004767568 | benign | DNAAF3-related condition | 2022-01-10 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |